EyeBrain Tracker for Early Diagnosis and Monitoring of Neurological Disease

This medical device includes a computer with two screens, a helmet, three software programs, and a recording device for taking eye movement measurements.

The EyeBrain Tracker (EBT) is an eyetracking medical device, which uses algorithms to accurately track eye movements for the diagnosis of Parkinson’s disease and multiple sclerosis. The brain uses many different areas to produce eye movements, so if an area of the brain does not function well, the eye movements it controls will produce an abnormal behavior.

altSince 1965, eye movements have been used to evaluate abnormalities and provide a link to the diagnosis of patients with neurological disorders. In particular, oculomotor abnormalities were used to evaluate the effect of the treatment in such patients. The study of eye movements has since become a valuable source of information for scientists and clinicians, as well as for neurobiologists, for whom the study of the control of eye movements provides a unique opportunity to understand the operation of the brain.

The EBT is comprised of several components, including a computer with two screens, a helmet, three software programs, and a recording device for highfrequency, accurate eye movement measurements. The EBT is also the only device of its kind to have obtained CE marking for medical use.

The eye exam is simple to carry out, non-invasive, and the results can be available in less than 20 minutes, even for patients at later stages of disease. Neurologists, ophthalmologists, and psychiatrists can learn to use the device with four hours of training.

During the exam, patients sit in front of a screen that displays ocular simulations to allow for automatic test analyses of their eye movements.

One of the tests, called “gap,” involves the display of a fixation cross in the center of the screen for 2,500–3,500 ms, and then removes the fixation cross for a time gap of 200 ms, followed by the appearance of a target on the right or on the left of the screen for 1,000 ms. This sequence is repeated for one minute and patients look at the fixation cross and the target as they appear. This test allows for the examination of reflexive saccades, which are rapid eye movements shifting the line of sight between successive points of fixation.

Different parameters of the saccades are automatically extracted and compared to normal values. One of these parameters is the reaction time (latency), which is the interval between the appearance of the target and the time when saccades start, while others include the saccadic velocity or the saccadic trajectory. Another type of test is called the “up down test” where the fixation cross is presented again for 2,500 to 3,500 ms. After the fixation cross is removed and a target is presented for 1,000 ms above or below the preceding position without a ‘time gap.’ As before, the sequence will be repeated for one minute. The patient looks at the fixation cross and the target when they appear. Measured parameters are the same as in the case of the gap test.

altA third type, called the “antisaccades test,” allows for the investigation of the control of voluntary saccades. Patients are required to suppress a saccade (the ‘prosaccade’) toward a stimulus that appears in the periphery vision, and asked to generate a voluntary saccade of equal size to the opposite side (the “antisaccade”) instead. Again, the stimuli displayed are the same as during the gap test, while the analyzed parameters include the number of errors as well as latency.

A fourth test called “pursuit” shows a target that is moving either horizontally or vertically, which the patient then needs to follow. In this kind of test, analyzers are monitoring the presence of jerks in the eye movements.

As patients use the EBT, any delay in being able to react or fixate on the target could be an indication of a neurological condition. For example, if a patient has difficulty in being able to normally move their eyes from the fixation cross to a target in the up down test, it is typically associated with that part of the brainstem not functioning well, which could suggest progressive supranuclear palsy (PSP), a Parkinsonian disorder.

White Papers

Meeting Industry Standards for Sanitation in The Food Industry
Sponsored by Able Electropolishing
Lubrication Considerations for Bearings
Sponsored by ast bearings
Tech Trend Report: Will GaN Knock out Silicon Semiconductors?
Sponsored by intercomp
The Road to Lightweight Vehicles
Sponsored by HP
Guidelines for Ensuring PCB Manufacturability
Sponsored by Sunstone Circuits
The Benefits of Integrated Video Management
Sponsored by Curtiss Wright

White Papers Sponsored By: